Sponsor of the Day:
Jerkmate
https://www.regmednet.com/cell-therapy-weekly-biotech-emerges-from-stealth-with-parkinsons-disease-program/
Cell Therapy Weekly: Biotech Emerges from Stealth - RegMedNet
Oryon Cell Therapies, specializing in autologous neuron replacement therapies for neurodegenerative disorders, has emerged from stealth.
cell therapy weeklybiotechemergesstealthregmednet
https://www.regmednet.com/cell-therapy-weekly-orphan-drug-designation-for-brain-cancer-car-t-cell-therapy/
Cell Therapy Weekly: Orphan Drug Designation for CAR-T Therapy - RegMedNet
Jul 11, 2025 - Mustang Bio's CAR T-cell therapy MB-101 for astrocytoma and glioblastoma has received Orphan Drug Designation.
cell therapy weeklyorphan drugdesignationcarregmednet
https://www.regmednet.com/cell-therapy-weekly-fujifilm-irvine-scientific-completes-construction-of-cell-culture-media-manufacturing-facility-in-the-netherlands/
Cell therapy weekly: Fujifilm Irvine Scientific completes construction of cell culture media...
Oct 27, 2021 - This week Fujifilm Irvine Scientific announces the completion of its new cell culture media manufacturing facility in the Netherlands, and much more.
cell therapy weeklycompletes constructionculture mediafujifilmirvine
https://www.regmednet.com/cell-therapy-weekly-phase-iii-results-for-brainstorm-cell-therapeutics-als-therapy-lead-to-rejection-by-fda-committee/
Cell therapy weekly: FDA rejects BrainStorm Cell Therapeutics ALS cell therapy, NurOwn
Sep 29, 2023 - The amyotrophic lateral sclerosis treatment was deemed to have insignificant therapeutic benefit leading to an FDA rejection.
cell therapy weeklyfdarejectsbrainstormtherapeutics